Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Personalis Inc. has 1 pending office action currently active in the Biotechnology & Pharmaceuticals technology area. Prosecution is localized, as the portfolio involves 1 distinct examiner and 1 distinct art unit for its pending matters. This structure indicates that the company's current interactions with the patent office are confined to a specific niche within the biotechnology sector, which allows for a very focused legal strategy.
WOITACH, JOSEPH T is identified as the busiest examiner, holding 1 pending office action. This represents the total volume of pending actions for the company, concentrating all current regulatory interaction with 1 official. For the practitioner, this means that the immediate success of the portfolio relies on navigating the specific preferences of this examiner. The presence of 1 art unit further suggests that the pending intellectual property is focused on a specific technological classification, requiring deep familiarity with the precedents of that particular unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHANG, KAIJIANG | 1 | 77.2% | +34.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19643058 | METHODS AND SYSTEMS FOR GENETIC ANALYSIS | ZHANG, KAIJIANG | — |
| Art Unit | Apps |
|---|---|
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19643058 | METHODS AND SYSTEMS FOR GENETIC ANALYSIS | ZHANG, KAIJIANG | 1684 | DP | Non-Final OA | — | Pending | Apr 09, 2026 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPersonalis Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kaijiang Zhang has the most, with 1 of Personalis Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
